Natural killer and natural killer-T cells in psoriasis

Archives of Dermatological Research

Volumn 294, Issue 8, 2002, Pages 363-369

  Cameron, A ^a   Kirby, B ^a   Fei, W ^a   Griffiths, C E M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

NK cells; NK T cells; Psoriasis

Indexed keywords

LEUKOCYTE ANTIGEN; CD158 ANTIGEN; CD16 ANTIGEN; CD161 ANTIGEN; CD2 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; CD94 ANTIGEN; CELL MARKER; CYTOKINE; TH1 CYTOKINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; HUMAN; IMMUNOLOGY; NATURAL KILLER CELL; PATHOLOGY; PSORIASIS; SKIN; T LYMPHOCYTE; ANTIGEN EXPRESSION; AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DERMIS; DERMOEPIDERMAL JUNCTION; FROZEN SECTION; HUMAN TISSUE; IMMUNOPEROXIDASE STAINING; PRIORITY JOURNAL; PSORIASIS VULGARIS; SKIN BIOPSY;

ADULT; ANTIGENS, CD; HUMANS; KILLER CELLS, NATURAL; PSORIASIS; SKIN; T-LYMPHOCYTES;

EID: 0036430093     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-002-0349-4     Document Type: Article

References (40)

1. Alcami A, Koszinowski UH (2000) Viral mechanisms of immune evasion. Immunol Today 21:447-455
2. Allen MH, Veal C, Faassen A, Powis SH, Vaughan RW, Trembath RC, Barker JN (1999) A non-HLA gene within the MHC in psoriasis. Lancet 353:1589-1590
3. Balendran N, Clough RL, Arguello JR, Barber R, Veal C, Jones AB, Rosbotham JL, Little AM, Madrigal A, Barker JN, Powis SH, Trembath RC (1999) Characterization of the major susceptibility region for psoriasis at chromosome 6p21.3. J Invest Dermatol 113:322-328
4. Bauer S, Groh V, Wu J, et al (1999) Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285:727-729
5. Bonish B, Jullien D, Dutronc Y, Huang BB, Modlin R, Spada FM, et al (2000) Overexpression of CD1d by keratinocytes in psoriasis and CD1d dependent IFN-gamma production by NK-T cells. J Immunol 165:4076-4085
6. Cameron AL, Kirby B, Griffiths CEM (2002) Circulating natural killer cells in psoriasis. Br J Dermatol (in press)
7. Camp RDR, Vekony MA (1998) Antigen receptor β-chain variable region usage by CD4+ and CD8+ T cells in psoriasis. J Invest Dermatol 110:987-988
8. + T cells in psoriatic lesions preferentially use T cell receptor Vβ3 and/or Vβ13.1 genes. Ann N Y Acad Sci 756:370-381
9. Cheng L, Zhang SZ, Xiao Y, Hou YP, Li L, Luo HC, Jiang HY, Zuo WQ (2000) The A5.1 allele of the MHC-class I chain-related gene is associated with psoriasis vulgaris in Chinese. Br J Dermatol 143:321-326
10. Cooper MA, Fehniger TA, Caliguri MA (2001) The biology of human natural killer-cell subsets. Trends Immunol 22:633-640
11. D'Auria L, Bonifati C, Cordiali-Fei P, Leone G, Picardo M, Pietravalle M, Giacalone B, Ameglio F (1999) Increased serum interleukin-15 levels in bullous skin diseases: Correlation with disease intensity. Arch Dermatol Res 291:354-356
12. de Boer OJ, van der Loos CM, Hamerlinck F, Bos JD, Das PK (1994) Reappraisal of in-situ immunophenotypic analysis of psoriasis skin: Interaction of activated HLA-DR+ immunocompetent cells and endothelial cells is a major feature of psoriatic lesions. Arch Dermatol Res 286:87-96
13. Falcone M, Yeung B, Tucker L, Rodriguez E, Sarvetnick N (1999) A defect in interleukin 12-induced activation and interferon-γ secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus. J Exp Med 190:963-972
14. Fehniger TA, Carson WE, Caligiuri MA (1999) Costimulation of human natural killer cells is required for interferon gamma production. Transplant Proc 31:1476-1478
15. Gottlieb SL, Gilleaudeau P, Johnson R, Estes L, Woodworth TG, Gottlieb AB, Krueger JG (1995) Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Med 1:442-447
16. Griffiths CE, Powles AV, Leonard JN, Fry L, Baker BS, Valdimarsson H (1986) Clearance of psoriasis with low dose cyclosporin. BMJ 293:731-732
17. Karpuj MV, Steinman L, Oksenberg JR (1997) Multiple sclerosis: A polygenic disease involving epistatic interactions, germline rearrangements and environmental effects. Neurogenetics 1:21-28
18. Kastrukoff LF, Morgan NG, Zecchini D, White R, Petkau AJ, Satoh J, Paty DW (1998) A role for natural killer cells in the immunopathogenesis of multiple sclerosis. J Neuroimmunol 86:123-133
19. Kastrukoff LF, Morgan NG, Zecchini D, White R, Petkau AJ, Satoh J, Paty DW (1999) Natural killer cells in relapsing-remitting MS: Effect of treatment with interferon beta-1B. Neurology 52:351-359
20. Kirby B, Al-Jiffri O, Cooper RJ, Corbitt G, Klapper PE, Griffiths CEM (2000) Investigation of cytomegalovirus and human herpes viruses 6 and 7 as possible causative antigens in psoriasis. Acta Derm Venereol 80:404-406
21. Koreck A, Suranyi A, Szony BJ, Farkas A, Bata-Csorgo Z, Kemeny L, Dobozy A (2002) CD3+CD56+ NKT cells are decreased in the peripheral blood of patients with psoriasis. Clin Exp Immunol 127:176-182
22. Kukreja A, MacLaren NK (1999) Autoimmunity and diabetes. J Clin Endocrinol Metab 84:4371-4378
23. Lanier LL (2000) The origin and functions of natural killer cells. Clin Immunol 95:S14-18
24. Lenz DC, Swanborg RH (1999) Suppressor cells in demyelinating disease: A new paradigm for the new millennium. J Neuroimmunol 100:53-57
25. Lopez-Bottet M, Bellon T, Llano M, Navarro F, Garcia P, de Miguel M (2000) Paired inhibitory and triggering NK cell receptors for HLA class I molecules. Hum Immunol 16:7-17
26. Majewski S, Jablonska S, Favre M, Ramoz N, Orth G (1999) Papilloma virus and autoimmunity in psoriasis. Immunol Today 20:475-476
27. Menssen A, Trommler P, Vollmer S, Schendel D, Albert E, Gurtler L, Riethmuller G, Prinz JC (1995) Evidence for an antigen specific cellular immune response in skin lesions of patients with psoriasis vulgaris. J Immunol 155:4078-4083
28. Mieza MA, Itoh T, Cui JQ, Makino Y, Kawano T, Tsuchida K, Kioke T, Shirai T, Yagita H, Matsuzawa A, Koseki H, Taniguchi M (1996) Selective reduction of V alpha 14+ NK T cells associated with disease development in autoimmune mice. J Immunol 156:4035-4040
29. Muraro PA, Vergelli M, Kalbus M, Banks DE, Nagle JW, Tranquill LR, Nepom GT, Biddison WE, McFarland HF, Martin R (1997) Immunodominance of a low affinity major histocompatibility complex-binding myelin basic protein epitope in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell repertoire. J Clin Invest 100:339-349
30. Nair RP, Henseler T, Jenisch S, Stuart P, Bichakjian CK, Lenk W, Westphal E, Guo SW, Christophers E, Voorhees JJ, Elder JT (1997) Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum Mol Genet 6:1349-1345
31. Nair RP, Stuart P, Henseler T, Jenisch S, Chia NV, Westphal E, Schork NJ, Kim J, Lim HW, Christophers E, Voorhees JJ, Elder JT (2000) Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet 66:1833-1844
32. Nickoloff BJ, Wrone-Smith T (1999) Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. Am J Pathol 155:145-158
33. Nickoloff BJ, Wrone-Smith T, Bonish B, Porcelli SA (1999) Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: Detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161. Arch Dermatol 135:546-552
34. Ortonne JP (1999) Recent developments in the understanding of the pathogenesis of psoriasis. Br J Dermatol 140 [Suppl 54]:1-7
35. Schlaak JF, Buslau M, Jochum W, Hermann E, Girndt M, Gallati H, Meyer zum Buschenfelde KH, Fleischer B (1994) T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 102:145-149
36. Simone E, Daniel D, Schloot N (1997) T cell receptor restriction of diabetogenic autoimmune NOD T cells. Proc Natl Acad Sci U S A 94:2518-2521
37. Valdimarsson H, Baker BS, Jonsdottir I, Powles AV, Fry L (1995) Psoriasis: A T-cell mediated autoimmune disease induced by streptococcal superantigens? Immunol Today 16:145-149
38. Waldmann TA, Tagaya Y (1999) The multi-faceted regulation of interleukin-15 expression and role of this cytokine in NK cell differentiation and host receptor intracellular pathogens. Annu Rev Immunol 17:19-49
39. Wang KS, Frank DA, Ritz J (2000) Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4. Blood 95:3183-3190
40. Yawalkar N, Karlen S, Hunger R, Brand CU, Braathen LR (1998) Expression of interleukin-12 is increased in psoriatic skin. J Invest Dermatol 111:1053-1057